These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome . Ashida A; Fujii Y; Matsumura H; Tamai H Int J Clin Pharmacol Ther; 2017 Mar; 55(3):264-269. PubMed ID: 27936525 [TBL] [Abstract][Full Text] [Related]
5. [The effects of glucocorticoid on bone architecture and strength]. Soen S Clin Calcium; 2013 Jul; 23(7):993-9. PubMed ID: 23811587 [TBL] [Abstract][Full Text] [Related]
6. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems]. Soen S Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
8. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. van Staa TP; Leufkens HG; Cooper C Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced osteoporosis: Insights for the clinician. Hayat S; Magrey MN Cleve Clin J Med; 2020 Jun; 87(7):417-426. PubMed ID: 32605977 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of the treatment of glucocorticoid-induced osteoporosis]. Asano S; Suzuki A Clin Calcium; 2013 Mar; 23(3):401-8. PubMed ID: 23445894 [TBL] [Abstract][Full Text] [Related]
19. Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Leib ES; Saag KG; Adachi JD; Geusens PP; Binkley N; McCloskey EV; Hans DB; J Clin Densitom; 2011; 14(3):212-9. PubMed ID: 21810527 [TBL] [Abstract][Full Text] [Related]
20. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]